Medicinal chemistry offers wide range of laboratory opportunities in pharmaceutical, biotechnological and medical device companies.This field connect many scientific disciplines in order to research and develop new drugs.
This document provides an overview of careers in drug discovery and development. It discusses the multi-stage process of discovering new drugs, from identifying drug targets through clinical trials and regulatory approval. The document notes that drug development is a highly time-intensive and costly process involving many disciplines. It also aims to dispel common myths about careers in the pharmaceutical industry, emphasizing that industry scientists have opportunities for publication, innovation, and interesting work.
Significance of BA/BE studies in drug research and evaluation of different as...inemet
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Factors influencing researchers' skill development processBhaswat Chakraborty
This document discusses the skills development process for researchers in pharmaceutical R&D. It covers the various stages of drug discovery and development from lead compound identification to regulatory approval and marketing. It emphasizes that most pharmaceutical R&D scientists have postgraduate degrees in relevant fields. Adaptation for fresh graduates to their new roles can be challenging but mentoring helps. Key skills discussed include analytical thinking, teamwork, leadership, budget and project management, as well as communication and problem-solving abilities. Finding the right mentor is also highlighted as important for career guidance.
Overcoming challenges in Drug DevelopmentCharles Oo
This document outlines strategies for overcoming challenges in drug development. It discusses the current long and expensive drug development process, as well as growing regulatory hurdles. It argues that innovation is needed, including open innovation models, a shift to personalized medicine, balancing drug toxicity and safety, leveraging technological advances like biomarkers, and using adaptive clinical trial designs. The key message is that new approaches are required to reduce costs, cycle times, and failure rates in drug development.
Challenges for drug development jsr slides aug 2013CincyTechUSA
This document discusses the challenges facing the pharmaceutical industry in drug development in the 21st century. It notes that R&D productivity has remained flat despite increased spending. Factors like the patent cliff, rising healthcare costs, and increased regulatory demands mean the industry can no longer rely on the blockbuster drug model. Innovation is now focused on targeted therapies for niche markets. Pharmacologists must guide drug development to demonstrate a new drug's safety, efficacy, and economic value in order to gain approval and reimbursement.
The document discusses the key stages in the drug discovery and development process including target selection, compound screening and hit optimization, selecting a drug candidate through further optimization of properties like absorption and metabolism, safety testing in animals and humans, proof of concept clinical trials in patients, large phase 3 clinical trials for registration and approval, and finally launch and life cycle management. It notes that the entire process from discovery to approval can take 12-16 years and cost over $1 billion.
Application of bio-pharmaceutics in new drug development .MD SAYDUR RAHMAN
Md. Saydur Rahman presented on the application of biopharmaceutics in new drug development. Biopharmaceutics studies the chemical and physical properties of drugs and their biological effects. Developing new drugs is a long, expensive process involving discovery, pre-clinical testing, clinical trials, and post-approval surveillance. Biopharmaceutics is important throughout this process to understand a drug's absorption, distribution, metabolism, and excretion. Early stages involve finding lead compounds through target identification and validation. Pre-clinical testing assesses toxicity, kinetics, and carcinogenicity in vitro and in vivo before human trials. Clinical trials have three phases to evaluate safety, efficacy, and side effects. Post-marketing surveillance monitors drugs after approval.
Basics of Drug Discovery and DevelopmentJhony Sheik
The document outlines the process of drug discovery and development from initial screening of chemicals to determine biological activity through clinical trials and regulatory approval. It notes that of 10,000 initially screened chemicals, only 1 may reach the market place due to the high costs, risks and regulatory hurdles. The key stages discussed are preclinical testing in animals, filing an Investigational New Drug application for human trials, conducting clinical trials in four phases, filing a New Drug Application providing trial results for regulatory review and approval, large-scale manufacturing, and filing an Abbreviated New Drug Application for generic approvals relying on previously approved drugs.
This document provides an overview of careers in drug discovery and development. It discusses the multi-stage process of discovering new drugs, from identifying drug targets through clinical trials and regulatory approval. The document notes that drug development is a highly time-intensive and costly process involving many disciplines. It also aims to dispel common myths about careers in the pharmaceutical industry, emphasizing that industry scientists have opportunities for publication, innovation, and interesting work.
Significance of BA/BE studies in drug research and evaluation of different as...inemet
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Factors influencing researchers' skill development processBhaswat Chakraborty
This document discusses the skills development process for researchers in pharmaceutical R&D. It covers the various stages of drug discovery and development from lead compound identification to regulatory approval and marketing. It emphasizes that most pharmaceutical R&D scientists have postgraduate degrees in relevant fields. Adaptation for fresh graduates to their new roles can be challenging but mentoring helps. Key skills discussed include analytical thinking, teamwork, leadership, budget and project management, as well as communication and problem-solving abilities. Finding the right mentor is also highlighted as important for career guidance.
Overcoming challenges in Drug DevelopmentCharles Oo
This document outlines strategies for overcoming challenges in drug development. It discusses the current long and expensive drug development process, as well as growing regulatory hurdles. It argues that innovation is needed, including open innovation models, a shift to personalized medicine, balancing drug toxicity and safety, leveraging technological advances like biomarkers, and using adaptive clinical trial designs. The key message is that new approaches are required to reduce costs, cycle times, and failure rates in drug development.
Challenges for drug development jsr slides aug 2013CincyTechUSA
This document discusses the challenges facing the pharmaceutical industry in drug development in the 21st century. It notes that R&D productivity has remained flat despite increased spending. Factors like the patent cliff, rising healthcare costs, and increased regulatory demands mean the industry can no longer rely on the blockbuster drug model. Innovation is now focused on targeted therapies for niche markets. Pharmacologists must guide drug development to demonstrate a new drug's safety, efficacy, and economic value in order to gain approval and reimbursement.
The document discusses the key stages in the drug discovery and development process including target selection, compound screening and hit optimization, selecting a drug candidate through further optimization of properties like absorption and metabolism, safety testing in animals and humans, proof of concept clinical trials in patients, large phase 3 clinical trials for registration and approval, and finally launch and life cycle management. It notes that the entire process from discovery to approval can take 12-16 years and cost over $1 billion.
Application of bio-pharmaceutics in new drug development .MD SAYDUR RAHMAN
Md. Saydur Rahman presented on the application of biopharmaceutics in new drug development. Biopharmaceutics studies the chemical and physical properties of drugs and their biological effects. Developing new drugs is a long, expensive process involving discovery, pre-clinical testing, clinical trials, and post-approval surveillance. Biopharmaceutics is important throughout this process to understand a drug's absorption, distribution, metabolism, and excretion. Early stages involve finding lead compounds through target identification and validation. Pre-clinical testing assesses toxicity, kinetics, and carcinogenicity in vitro and in vivo before human trials. Clinical trials have three phases to evaluate safety, efficacy, and side effects. Post-marketing surveillance monitors drugs after approval.
Basics of Drug Discovery and DevelopmentJhony Sheik
The document outlines the process of drug discovery and development from initial screening of chemicals to determine biological activity through clinical trials and regulatory approval. It notes that of 10,000 initially screened chemicals, only 1 may reach the market place due to the high costs, risks and regulatory hurdles. The key stages discussed are preclinical testing in animals, filing an Investigational New Drug application for human trials, conducting clinical trials in four phases, filing a New Drug Application providing trial results for regulatory review and approval, large-scale manufacturing, and filing an Abbreviated New Drug Application for generic approvals relying on previously approved drugs.
This paper aims to study various strategies adopted by pharmaceutical companies to boost innovation. These strategies are usually overlapping and must not be viewed as watertight initiatives.
The penetration of the aforesaid strategies may differ with each pharma. However, on a superficial level it is safe to say that pharmas will largely look outside its own company for drug innovation and early development requirements. This trend will also be enhanced by the fact that most of the late stage drug candidates have already been licensed, and hence the focus will shift to an early stage. The success of these strategies will depend on how many potential drugs will be approved after clinical trials for commercialization.
Re-Engineering Early Phase Cancer Drug Development: Decreasing the Time from ...mconghuyen
The document summarizes efforts to decrease the time required to develop novel cancer therapeutics from target identification to clinical use. It describes how most oncology drugs fail in late stages of development, particularly phases 2 and 3, due to lack of efficacy. To address this, the National Cancer Institute has created programs like the Experimental Therapeutics Program and Chemical Biology Consortium to streamline the discovery and development process. This includes providing resources from target validation through early clinical trials to support academic and biotech projects focusing on areas of unmet medical need. The goal is to rapidly translate discoveries into treatments to benefit public health.
In silico Drug Design: Prospective for Drug Lead Discoveryinventionjournals
International Journal of Engineering and Science Invention (IJESI) is an international journal intended for professionals and researchers in all fields of computer science and electronics. IJESI publishes research articles and reviews within the whole field Engineering Science and Technology, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Introduction to the drug discovery processThanh Truong
This document discusses the drug discovery process from target identification through FDA approval. It describes methods used for target identification such as genomics, bioinformatics, and proteomics. The stages of lead identification through high-throughput screening and structure-based drug design are outlined. Key aspects of lead optimization like characterizing potency, efficacy, pharmacokinetics, and toxicity are summarized. Details are provided on preclinical and clinical trial phases from Phase 0 through Phase IV post-marketing surveillance. Factors contributing to the declining drug approval rate like increased safety demands are noted. The high costs and failure rates associated with drug development are highlighted.
The document discusses the process of new drug development, which involves several lengthy and costly stages. In preclinical testing, potential drug candidates are screened in animal and laboratory testing to evaluate toxicity, safety, and efficacy. If successful, compounds enter clinical trials involving 4 phases with human subjects to further assess safety and effectiveness. Only about 1-2% of initially investigated compounds ultimately result in an approved drug. The entire process from discovery to regulatory approval can take over 12 years and cost over $1 billion. Rigorous testing and regulatory standards aim to bring only safe and effective drugs to market.
This document discusses pharmaceutical regulations and their impact on ensuring sterility and quality control. It addresses how strict definitions of sterility are defined quantitatively in terms of probability of a non-sterile unit. Proper management of aseptic processing areas and personnel training are essential to maintaining sterility. Inspectors focus on facilities, equipment, materials, and documentation to ensure quality management systems prevent inferior products. Sources of particulate contamination include environmental factors, packaging materials, product interactions, and process issues. Intravenous administration of particulates carries the highest risk, as particles can disseminate throughout the body and block vessels. Large particle loads, irregular shapes, and vulnerable patient populations increase risks of adverse effects.
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences
BOC Sciences recently updated its product list of pharmaceutical impurity reference standards to better serve pharmaceutical companies, scientific research units, testing institutions and universities. Visit https://www.bocsci.com/products/impurities-8.html for more information.
Generic drug companies are relying heavily on qualified contract research organizations (CROs) to accelerate their development processes and be first to market after patents expire on branded drugs. CROs provide expertise across development areas like preclinical research, clinical trials management, bioequivalence studies, analytical testing, and ANDA submissions that help generics meet tight deadlines. Successfully demonstrating bioequivalence through bioavailability and dissolution studies is key for regulatory approval and requires CROs with strong laboratory capabilities and experience navigating regulatory requirements.
Drug Development Life Cycle - Costs and RevenueRobert Sturm
Presentation explains the Drug Development Process in terms of time/costs from initial research to final manufacturing. It presents strategies for increasing profits/decreasing costs, shows the impact of generics and details how Information Technology fits into this equation. It uses research from DiMasi and Grabowski to identify drug costs and product revenue.
The clinical research industry in India is growing rapidly due to the booming pharmaceutical sector. The Indian pharmaceutical market is expected to triple in size by 2015. This growth has fueled a rise in clinical research opportunities in India. However, the clinical research industry faces high attrition rates. There is a high demand for trained clinical research professionals to work for the growing number of contract research organizations. Focus Edu Care has launched a postgraduate program in clinical research to train professionals to meet this demand and fill various roles in areas like clinical research, data management, business development, and medical writing.
this slide share will provide information about drug discovery and development.in this, how the drug is discovered and what type of procedures and instructions followed during discovery and development of a new drug and also give limitations of drug discovery and development process.
This document provides an overview of regulatory affairs and the new drug development process. It defines regulatory affairs as a profession focused on collecting, analyzing, and communicating risk-benefit information of healthcare products to regulatory agencies. The new drug development process involves discovery, pre-clinical studies, investigational new drug application, clinical trials, new drug application, and post-marketing activities. Key goals of regulatory affairs include protecting human health, ensuring safety and efficacy, and providing accurate product information.
Typically, researchers discover new drugs through: New insights into a disease process that allow researchers to design a product to stop or reverse the effects of the disease. Many tests of molecular compounds to find possible beneficial effects against any of a large number of diseases.
The document is a presentation by Obaid Ali on microbiology and pharmaceutical transformation. It discusses topics like clinical trials, new and generic drug manufacturing, vigilance, research, microbiology, human safety and efficacy verification, quality claims, consistency, contamination, surveillance, and signals from vigilance. Ali has experience working at the FDA and Health Canada and is currently leading scientific transformation initiatives at DRAP and advising the Centre for Quality Science.
Regulatory requirements for drug approval unit3Aman chourasia
New Drug Application (NDA) is an application submitted to the individual regulatory authority for authorization to market a new drug i.e. innovative product. To gain this permission a sponsor submits preclinical and clinical test data for analyzing the drug information, description of manufacturing trials.
Drug repurposing involves finding new uses for existing drugs to treat different diseases. It provides a more efficient and lower cost alternative to traditional drug development. Computational approaches like network-based, text mining, and semantic methods are used to discover novel drug-disease relationships for drug repurposing. These include identifying modules in biological networks, propagating information across networks, extracting relationships from literature, and constructing semantic networks to predict new associations. Drug repurposing reduces costs and risks compared to de novo drug development.
Drug discovery is a process that involves target identification, validation, lead identification and optimization, and preclinical and clinical testing in humans. The goal is to identify compounds that can safely and effectively treat diseases. Preclinical testing assesses safety and efficacy in cells and animals. If promising, an Investigational New Drug application is filed with the FDA and clinical trials in humans begin. Clinical trials have phases to test safety, efficacy, side effects, and optimal dosage in healthy volunteers and patients. If successful, a New Drug Application is filed with the FDA to verify the drug is safe and effective for its proposed use.
Presented By :- Raghav Sharma
Class :- M.Pharm, 1st sem.
Department :- Pharmaceutics
Institute :- Parul Institute of Pharmacy
Content :-
Introduction to Clinical trials
Importance of Clinical Trials
Phase-I of Clinical Trials
Phase-II of Clinical Trials
Phase-III of Clinical Trials
Phase-IV of Clinical Trials
Conclusion
References
Pre-clinical trials involve testing new drugs, procedures, or medical treatments in animals before beginning clinical trials in humans. They aim to determine safety and efficacy. The document outlines the stages of pre-clinical trials including in vitro and in vivo testing, pharmacokinetic studies, toxicity tests, and FDA review requirements. The goals are to identify safe starting doses in humans, target organs for toxicity, and safety parameters for clinical monitoring before human trials.
Young pharmaceutical scientists are and can get involved in all aspects of new drug discovery and development. They have to be appropriately qualified, trained and experienced though,
A pharmacologist has several key roles:
1. Medical education - Teaching undergraduate and postgraduate students about rational drug use, effects, toxicity, and interactions.
2. Research - Conducting both basic and clinical research, ensuring adherence to guidelines for clinical trials and ethical reviews.
3. Regulatory affairs - Involved in essential drug lists, national drug policy, and regulatory bodies like drug authorities.
This paper aims to study various strategies adopted by pharmaceutical companies to boost innovation. These strategies are usually overlapping and must not be viewed as watertight initiatives.
The penetration of the aforesaid strategies may differ with each pharma. However, on a superficial level it is safe to say that pharmas will largely look outside its own company for drug innovation and early development requirements. This trend will also be enhanced by the fact that most of the late stage drug candidates have already been licensed, and hence the focus will shift to an early stage. The success of these strategies will depend on how many potential drugs will be approved after clinical trials for commercialization.
Re-Engineering Early Phase Cancer Drug Development: Decreasing the Time from ...mconghuyen
The document summarizes efforts to decrease the time required to develop novel cancer therapeutics from target identification to clinical use. It describes how most oncology drugs fail in late stages of development, particularly phases 2 and 3, due to lack of efficacy. To address this, the National Cancer Institute has created programs like the Experimental Therapeutics Program and Chemical Biology Consortium to streamline the discovery and development process. This includes providing resources from target validation through early clinical trials to support academic and biotech projects focusing on areas of unmet medical need. The goal is to rapidly translate discoveries into treatments to benefit public health.
In silico Drug Design: Prospective for Drug Lead Discoveryinventionjournals
International Journal of Engineering and Science Invention (IJESI) is an international journal intended for professionals and researchers in all fields of computer science and electronics. IJESI publishes research articles and reviews within the whole field Engineering Science and Technology, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Introduction to the drug discovery processThanh Truong
This document discusses the drug discovery process from target identification through FDA approval. It describes methods used for target identification such as genomics, bioinformatics, and proteomics. The stages of lead identification through high-throughput screening and structure-based drug design are outlined. Key aspects of lead optimization like characterizing potency, efficacy, pharmacokinetics, and toxicity are summarized. Details are provided on preclinical and clinical trial phases from Phase 0 through Phase IV post-marketing surveillance. Factors contributing to the declining drug approval rate like increased safety demands are noted. The high costs and failure rates associated with drug development are highlighted.
The document discusses the process of new drug development, which involves several lengthy and costly stages. In preclinical testing, potential drug candidates are screened in animal and laboratory testing to evaluate toxicity, safety, and efficacy. If successful, compounds enter clinical trials involving 4 phases with human subjects to further assess safety and effectiveness. Only about 1-2% of initially investigated compounds ultimately result in an approved drug. The entire process from discovery to regulatory approval can take over 12 years and cost over $1 billion. Rigorous testing and regulatory standards aim to bring only safe and effective drugs to market.
This document discusses pharmaceutical regulations and their impact on ensuring sterility and quality control. It addresses how strict definitions of sterility are defined quantitatively in terms of probability of a non-sterile unit. Proper management of aseptic processing areas and personnel training are essential to maintaining sterility. Inspectors focus on facilities, equipment, materials, and documentation to ensure quality management systems prevent inferior products. Sources of particulate contamination include environmental factors, packaging materials, product interactions, and process issues. Intravenous administration of particulates carries the highest risk, as particles can disseminate throughout the body and block vessels. Large particle loads, irregular shapes, and vulnerable patient populations increase risks of adverse effects.
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences
BOC Sciences recently updated its product list of pharmaceutical impurity reference standards to better serve pharmaceutical companies, scientific research units, testing institutions and universities. Visit https://www.bocsci.com/products/impurities-8.html for more information.
Generic drug companies are relying heavily on qualified contract research organizations (CROs) to accelerate their development processes and be first to market after patents expire on branded drugs. CROs provide expertise across development areas like preclinical research, clinical trials management, bioequivalence studies, analytical testing, and ANDA submissions that help generics meet tight deadlines. Successfully demonstrating bioequivalence through bioavailability and dissolution studies is key for regulatory approval and requires CROs with strong laboratory capabilities and experience navigating regulatory requirements.
Drug Development Life Cycle - Costs and RevenueRobert Sturm
Presentation explains the Drug Development Process in terms of time/costs from initial research to final manufacturing. It presents strategies for increasing profits/decreasing costs, shows the impact of generics and details how Information Technology fits into this equation. It uses research from DiMasi and Grabowski to identify drug costs and product revenue.
The clinical research industry in India is growing rapidly due to the booming pharmaceutical sector. The Indian pharmaceutical market is expected to triple in size by 2015. This growth has fueled a rise in clinical research opportunities in India. However, the clinical research industry faces high attrition rates. There is a high demand for trained clinical research professionals to work for the growing number of contract research organizations. Focus Edu Care has launched a postgraduate program in clinical research to train professionals to meet this demand and fill various roles in areas like clinical research, data management, business development, and medical writing.
this slide share will provide information about drug discovery and development.in this, how the drug is discovered and what type of procedures and instructions followed during discovery and development of a new drug and also give limitations of drug discovery and development process.
This document provides an overview of regulatory affairs and the new drug development process. It defines regulatory affairs as a profession focused on collecting, analyzing, and communicating risk-benefit information of healthcare products to regulatory agencies. The new drug development process involves discovery, pre-clinical studies, investigational new drug application, clinical trials, new drug application, and post-marketing activities. Key goals of regulatory affairs include protecting human health, ensuring safety and efficacy, and providing accurate product information.
Typically, researchers discover new drugs through: New insights into a disease process that allow researchers to design a product to stop or reverse the effects of the disease. Many tests of molecular compounds to find possible beneficial effects against any of a large number of diseases.
The document is a presentation by Obaid Ali on microbiology and pharmaceutical transformation. It discusses topics like clinical trials, new and generic drug manufacturing, vigilance, research, microbiology, human safety and efficacy verification, quality claims, consistency, contamination, surveillance, and signals from vigilance. Ali has experience working at the FDA and Health Canada and is currently leading scientific transformation initiatives at DRAP and advising the Centre for Quality Science.
Regulatory requirements for drug approval unit3Aman chourasia
New Drug Application (NDA) is an application submitted to the individual regulatory authority for authorization to market a new drug i.e. innovative product. To gain this permission a sponsor submits preclinical and clinical test data for analyzing the drug information, description of manufacturing trials.
Drug repurposing involves finding new uses for existing drugs to treat different diseases. It provides a more efficient and lower cost alternative to traditional drug development. Computational approaches like network-based, text mining, and semantic methods are used to discover novel drug-disease relationships for drug repurposing. These include identifying modules in biological networks, propagating information across networks, extracting relationships from literature, and constructing semantic networks to predict new associations. Drug repurposing reduces costs and risks compared to de novo drug development.
Drug discovery is a process that involves target identification, validation, lead identification and optimization, and preclinical and clinical testing in humans. The goal is to identify compounds that can safely and effectively treat diseases. Preclinical testing assesses safety and efficacy in cells and animals. If promising, an Investigational New Drug application is filed with the FDA and clinical trials in humans begin. Clinical trials have phases to test safety, efficacy, side effects, and optimal dosage in healthy volunteers and patients. If successful, a New Drug Application is filed with the FDA to verify the drug is safe and effective for its proposed use.
Presented By :- Raghav Sharma
Class :- M.Pharm, 1st sem.
Department :- Pharmaceutics
Institute :- Parul Institute of Pharmacy
Content :-
Introduction to Clinical trials
Importance of Clinical Trials
Phase-I of Clinical Trials
Phase-II of Clinical Trials
Phase-III of Clinical Trials
Phase-IV of Clinical Trials
Conclusion
References
Pre-clinical trials involve testing new drugs, procedures, or medical treatments in animals before beginning clinical trials in humans. They aim to determine safety and efficacy. The document outlines the stages of pre-clinical trials including in vitro and in vivo testing, pharmacokinetic studies, toxicity tests, and FDA review requirements. The goals are to identify safe starting doses in humans, target organs for toxicity, and safety parameters for clinical monitoring before human trials.
Young pharmaceutical scientists are and can get involved in all aspects of new drug discovery and development. They have to be appropriately qualified, trained and experienced though,
A pharmacologist has several key roles:
1. Medical education - Teaching undergraduate and postgraduate students about rational drug use, effects, toxicity, and interactions.
2. Research - Conducting both basic and clinical research, ensuring adherence to guidelines for clinical trials and ethical reviews.
3. Regulatory affairs - Involved in essential drug lists, national drug policy, and regulatory bodies like drug authorities.
The pharmaceutical industry is facing challenges developing new drugs due to limited knowledge of biology and chemistry. There are only about 500 validated drug targets and 9,500 known chemical compounds. The industry has relied on developing oral small-molecule drugs but is running out of viable targets and compounds. To succeed in the future, companies will need to accelerate target validation, invest more in new areas like genomics and proteomics, broaden their portfolios, and increase collaboration with external partners to gain expertise in areas like biologics development.
Careers in Pharmacy in India, 1. Pharmacist, 2. Drug Inspector, 3. Governmental Agencies, 4. As Government Analyst, 5. Clinical Pharmacy, 6. Community Pharmacy, 7. Nuclear Pharmacy, 8. Pharmaceutical Industry, 9. Drug researcher, 10. As Manufacturing Chemist, 11. In Quality Control / Quality Assurance, 12. Clinical Research, 13. Medical Communications/ Information, 14. Medical Transcription, 15. Medical Coding 16. In Regulatory Affairs 17. Sales and Marketing 18. Pharma-Biotechnology, 19. Academic Pharmacy, 20. Health policy makers, 21. Specialized Area Opportunities, 22. Higher Studies With Research Fellowship
Career in pharmacy and scope of pharmacy. Pharma industry, Hospital pharmacy , Community Pharmacy, Teaching in Pharmacy, Sales & Marketing , Clinical research , Career in Regulatory Body, Biotechnology, Cosmetic, Food Industry etc.
There are many career options available to pharmacists with a PharmD degree beyond just working in a retail pharmacy setting. Some of the major options include working in hospital pharmacies providing medication management services; industrial pharmacy roles in research, development, production, and quality control; government agency roles ensuring safety standards; roles in pharmaceutical education and research; nuclear pharmacy preparing radioactive materials; clinical research associate roles overseeing trials; and roles in sales, marketing, and community pharmacy patient services. Compensation remains relatively consistent across these varied practice settings.
regulatory requirements for drug approval ( IP-2 / UNIT -3 )JAYACHANDRA AKUTHOTA
The document discusses regulatory requirements for drug approval. It covers the drug development process including non-clinical and clinical development teams. The non-clinical team conducts pre-clinical studies in animals to evaluate efficacy, safety, and viability of manufacturing. Clinical trials have multiple phases to test drugs on humans. A New Drug Application is submitted to regulatory authorities for marketing approval and includes preclinical and clinical data. The drug development process takes 10-12 years and involves interactions between scientific disciplines.
Career Opportunities for Biochemistry Graduates _ Entry LevelFrancis Awah
Most biochemistry graduates are at the cross road of decision after graduation. This presentation is a guide for Biochemistry graduates who are considering entry levels careers or entrepreneurial opportunities.
PHARMACY -INTRODUCTION AND GENERAL DEFINITIONSvarinder kumar
Pharmacy is a health profession that links health sciences with chemical sciences to ensure safe and effective use of pharmaceutical drugs. Pharmacists prepare and dispense prescription drugs and provide advice on their proper use. Pharmacy technicians support pharmacists by dispensing drugs, handling administrative duties, and instructing patients. The field of pharmacy involves sciences like pharmacology, pharmacokinetics, and pharmaceutics. Pharmacists work in various settings like hospitals, clinics, and retail pharmacies. Key symbols of pharmacy include the Rod of Asclepius and the mortar and pestle.
The document describes the Master of Science in Regulatory Science program offered by the University of Maryland School of Pharmacy. The two-year program can be completed part-time and exclusively online, with five courses taken over five semesters. The science-driven program focuses on drug development and regulation, and teaches skills like developing global drug strategies and differentiating regulatory requirements. Graduates will be prepared for regulatory careers in government agencies like the FDA or in the pharmaceutical industry. The program is complemented by the University's Center of Excellence in Regulatory Science and Innovation, funded by the FDA to support new regulatory assessment tools.
This document discusses key concepts in pharmaceutics and drug development. It covers:
1. The branches of pharmaceutics including pharmacokinetics, pharmacodynamics, biopharmaceutics, and pharmaceutical technology.
2. The process of drug discovery and development, from identifying drug targets through preclinical and clinical testing.
3. The different phases of clinical trials and timelines for drug approval.
4. The definitions of key terms used in drug development like target, hit, lead, candidate, and product.
5. The differences between brand drugs, generics, and biosimilars.
Pharm D role in improving Pharma industry ventureARUNRAJKALICHAMY
This document discusses the role of Pharm Ds in improving the pharmaceutical industry. It begins with an introduction to the Pharm D degree, which is a six-year program in India involving courses in various medical and scientific fields. The document then outlines several roles Pharm Ds can have, including in regulatory affairs, site management, formulation, price fixing, and marketing. It provides details on the responsibilities in regulatory affairs, formulation research, pharmacokinetics research, and considerations around drug price and pharmacoeconomics. Finally, it lists some positions in the pharmaceutical industry suited for Pharm Ds.
Full detailed about pharmacy and Scope of pharmacy like Formulation and development, Manufacturing, Packaging, Pharmaceutical marketing, Drug inspector, research and development, Academic area and work of drug analyst.
Biopharma Informatic, Inc. is a site management organization (SMO) that recruits patients and physicians for clinical trials on behalf of pharmaceutical companies and contract research organizations. As an SMO, it facilitates clinical research by finding suitable trial locations and participants. The company aims to establish a nationwide network and expand globally to meet increasing demand from clients in the rapidly growing clinical research industry.
Pharmacology is the study of drugs, their sources, nature, and properties. The scope of pharmacology has expanded to include new areas like proteomics, pharmacogenomics, bioinformatics, and nanomedicine. Current areas of focus include drug development, discovery, and clinical trials. Pharmacology also contributes to undergraduate and postgraduate education as well as research and industries like medical advising and new drug development. Pharmacology is crucial to advancing medicine and remains an important field.
Community pharmacies and consultant pharmacists provide health information and advice to over two billion patients annually. Pharmacists in hospitals and other institutions have direct involvement in patient care through drug distribution systems and addressing drug allergies and adverse effects. The pharmaceutical industry employs pharmacists in roles like marketing, research, quality control, and administration for drug development and production. Academic pharmacy positions include faculty who work in teaching, research, and patient care at colleges of pharmacy, with pharmaceutical scientists focused on advanced drug research. Other opportunities for pharmacists exist in public health services, the Food and Drug Administration, and the military.
Part 2: Career Opportunities for Biochemistry GraduatesFrancis Awah
Many Biochemistry graduates are at a cross road of decision after graduation. With a post graduate degree, candidates are qualified for mid-level and senior level job opportunities. In this presentation, some career options are highlighted.
This document discusses pharmacy as a career and the scope of pharmacy. It explains that pharmacists are experts in medicines who play a key role in healthcare by developing new medicines, supplying medicines, providing advice about medicines, and offering health services. Pharmacists work in various settings like universities, research, and the pharmaceutical industry. They educate patients, advise other healthcare professionals, and ensure drug purity, strength, and that drugs do not interact harmfully. The pros of a pharmacy career include job security, flexibility, rewards, and variety, while the cons can include a competitive field and long or physically demanding hours. Pharmacists have opportunities in government service roles like the military, regulation, analysis, and hospitals.
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLSKatalyst HLS
Introduction to Discovery of Drug and Introduction to Clinical Trials in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Electronic commerce( e- commerce) is a relatively new area of business management and information technology and is continually changing with the technological advancement. E-commerce has four driving factors- social, technological, economic, and political and impact upon a wide range of different areas.
The GMAT is a standardized test used by graduate business programs to assess candidates' abilities in critical thinking, analytical writing, integrated reasoning, quantitative reasoning, and verbal reasoning. It takes 3.5 hours to complete and provides flexibility in section order. Over 2,100 universities in 114 countries use GMAT scores, which remain valid for 5 years, to help admit students and predict their potential for success in graduate business programs.
Commerce programs offer significant flexibility and diversity for students. Students will acquire the skills and knowledge to meet the challenges of a changing business environment, develop the ability to critically analyse emerging business issues, and be exposed to scholarly research in the national and global business arena. Achieving these academic and professional qualities will lead you to a wide range of business related professions and careers, or progress to more advanced studies.
The document discusses the field of radiology including courses, careers, and job opportunities. It notes that the need for radiologists is increasing due to growth in the field. Courses range from certificate to masters level and include subjects like radiography, radiotherapy, and medical imaging. Popular career paths include roles as a radiologist, radiology technician, MRI technician, and ultrasound or CT scan technologist. Graduates can find employment in hospitals, clinics, diagnostic centers, and other healthcare facilities.
Epidemiology is defined as the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to control health problems. Some key principles of epidemiology are that it studies incidence and patterns of health issues over time, place and personal characteristics (distribution) and seeks to understand causes and risk factors (determinants). Applied epidemiology aims to monitor diseases, evaluate programs and plan public health resources to deal with a wide range of health issues and keep communities healthy.
Social media platforms like Facebook, Instagram, and Twitter provide advantages for business advertising and marketing by allowing companies to reach millions of potential customers quickly and at a low cost. Social media advertising increases brand visibility to large audiences and can improve brand loyalty through content shared organically by users. Creating high-quality pages and content takes only a few hours but can potentially reach millions on social media.
Influencer marketing uses influential leaders to promote a brand's message to a large audience. It identifies people with large social followings who can influence target consumers. An effective influencer marketing campaign identifies key influencers, builds a campaign around them, and measures metrics like reach, sales, and awareness. Influencer marketing is more trusted than traditional ads because it leverages social proof and word-of-mouth recommendations from influencers their audiences respect.
New media marketing utilizes evolving online channels like websites, search engines, social media, email newsletters, online video and forums to promote products, services and brands. As the web has become primary for research and communication, marketers have shifted from traditional to online marketing. Organizations use new media marketing and track metrics like website traffic, bounce rates and dwell time to monitor campaign success and inform future planning. New media tools allow businesses to gain success through online platforms with wise planning rather than traditional salesperson conversations.
Media Science involves the study of mass media including print, audio, and audiovisual media. It covers topics like advertising, public relations, and event management. Students can pursue various career paths after graduation like journalists, media planners, public relations officers, and producers. Both students and industry stakeholders benefit from media science - students gain practical skills and updated knowledge, while stakeholders can leverage students' expertise in evolving media platforms.
Cloud computing is a technology that allows programs and services to be delivered over the Internet. It allows everything from email to complex data analysis programs to be hosted remotely on servers that make up the "cloud." Organizations use cloud computing to manage computer operations and resources more efficiently. All that is needed to access cloud services is a computer, web browser, and Internet connection. Cloud computing provides quick solutions and has become essential for many organizations. It reduces costs associated with software, hardware, and data center maintenance.
MBA in HR covers topics related to management of the people and few finance and commerce
related subjects like Ethics and Responsibility, Competitive Strategy, Managerial Economics and
Statistics, People Management, Decision Models and Uncertainty, Financial Accounting, Government
and Legal Frameworks for Business, Financial Management, Macro-Economics, Organizational
Change, Company Hierarchy, Power and Influence, Management Communication, Operations
Management, Supply Chain, Managerial Statics and some electives in order to give a feel or other
subject which are directly or indirectly related to Human Resources.
The field of Biotechnology focuses on the intersection of biology and technology, leading to a vast array of new products that are designed to enrich lives, make day-to-day living easier, and make us healthier. From vaccine production to genetic modification, biotechnology is everywhere – and as a result, biotechnology careers are quite promising for new graduates. This guide focuses on the various biotechnology degrees, jobs and expectations for those who are interested in the field.
Traditionally, the field of optometry began with the primary focus of correcting refractive error through the use of spectacles. Modern day optometry, however, has evolved through time so that the educational curriculum additionally includes significant training in the diagnosis and management of ocular disease, in most of the countries of the world, where the profession is established and regulated.
There are several colleges/institutions offering Law courses for higher studies in West Bengal. All you need to do is a good research on the courses, fee structure, placement facility, etc. to be well acquainted and get aware with the colleges. Here is a good look of a few of them.
ECE has a great demand in the market and it involved lots of opportunities. Students can also pursue in the field of communications and networking work area. For ECE Students there is many scope to get into the IT industry.
The Emerging careers offers a chance to make the field clear for the students. Well, there is nothing more than challenging the objective of your goals and converting them from dream to the reality.
It is a platform to show the talent and efforts put by students to make the events successful. Annual sports is not only about competitions, it also about having fun, being physically active and can get the basic knowledge of sports and can create a teamwork so that students can get opportunity to use their talent build self confidence.
Brainware university:The Studentpreneurs the steps towards Idea HuntBrainware University
The main aim of the programme is to encourage students to come up with digital solutions in real life problems and to convert their ideas into successful business.
2) It's a challenging thing to do but it comes with a lot of advantage.Students can get unique skills and think outside the box. It will help to learn from different social and economic backgrounds.
It will help you to improve your memory recall and to make your brain work continuously will make it a little stronger. People can learn about the past by talking to people who remember things that happened in the past so that history will not be lost.
Students interested in law have opportunities to study legal history and gain practical legal skills. A workshop provided guidance on cracking competitive exams for legal careers and focused on understanding over memorization. Guest speakers discussed the importance of statutes and case laws, and shared expertise in cross-examination. Studying law offers entry into various law firms and positions beyond legal work in fields like business and administration.
Introduction of Cybersecurity with OSS at Code Europe 2024Hiroshi SHIBATA
I develop the Ruby programming language, RubyGems, and Bundler, which are package managers for Ruby. Today, I will introduce how to enhance the security of your application using open-source software (OSS) examples from Ruby and RubyGems.
The first topic is CVE (Common Vulnerabilities and Exposures). I have published CVEs many times. But what exactly is a CVE? I'll provide a basic understanding of CVEs and explain how to detect and handle vulnerabilities in OSS.
Next, let's discuss package managers. Package managers play a critical role in the OSS ecosystem. I'll explain how to manage library dependencies in your application.
I'll share insights into how the Ruby and RubyGems core team works to keep our ecosystem safe. By the end of this talk, you'll have a better understanding of how to safeguard your code.
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-und-domino-lizenzkostenreduzierung-in-der-welt-von-dlau/
DLAU und die Lizenzen nach dem CCB- und CCX-Modell sind für viele in der HCL-Community seit letztem Jahr ein heißes Thema. Als Notes- oder Domino-Kunde haben Sie vielleicht mit unerwartet hohen Benutzerzahlen und Lizenzgebühren zu kämpfen. Sie fragen sich vielleicht, wie diese neue Art der Lizenzierung funktioniert und welchen Nutzen sie Ihnen bringt. Vor allem wollen Sie sicherlich Ihr Budget einhalten und Kosten sparen, wo immer möglich. Das verstehen wir und wir möchten Ihnen dabei helfen!
Wir erklären Ihnen, wie Sie häufige Konfigurationsprobleme lösen können, die dazu führen können, dass mehr Benutzer gezählt werden als nötig, und wie Sie überflüssige oder ungenutzte Konten identifizieren und entfernen können, um Geld zu sparen. Es gibt auch einige Ansätze, die zu unnötigen Ausgaben führen können, z. B. wenn ein Personendokument anstelle eines Mail-Ins für geteilte Mailboxen verwendet wird. Wir zeigen Ihnen solche Fälle und deren Lösungen. Und natürlich erklären wir Ihnen das neue Lizenzmodell.
Nehmen Sie an diesem Webinar teil, bei dem HCL-Ambassador Marc Thomas und Gastredner Franz Walder Ihnen diese neue Welt näherbringen. Es vermittelt Ihnen die Tools und das Know-how, um den Überblick zu bewahren. Sie werden in der Lage sein, Ihre Kosten durch eine optimierte Domino-Konfiguration zu reduzieren und auch in Zukunft gering zu halten.
Diese Themen werden behandelt
- Reduzierung der Lizenzkosten durch Auffinden und Beheben von Fehlkonfigurationen und überflüssigen Konten
- Wie funktionieren CCB- und CCX-Lizenzen wirklich?
- Verstehen des DLAU-Tools und wie man es am besten nutzt
- Tipps für häufige Problembereiche, wie z. B. Team-Postfächer, Funktions-/Testbenutzer usw.
- Praxisbeispiele und Best Practices zum sofortigen Umsetzen
Trusted Execution Environment for Decentralized Process MiningLucaBarbaro3
Presentation of the paper "Trusted Execution Environment for Decentralized Process Mining" given during the CAiSE 2024 Conference in Cyprus on June 7, 2024.
GraphRAG for Life Science to increase LLM accuracyTomaz Bratanic
GraphRAG for life science domain, where you retriever information from biomedical knowledge graphs using LLMs to increase the accuracy and performance of generated answers
HCL Notes and Domino License Cost Reduction in the World of DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
Building Production Ready Search Pipelines with Spark and MilvusZilliz
Spark is the widely used ETL tool for processing, indexing and ingesting data to serving stack for search. Milvus is the production-ready open-source vector database. In this talk we will show how to use Spark to process unstructured data to extract vector representations, and push the vectors to Milvus vector database for search serving.
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/temporal-event-neural-networks-a-more-efficient-alternative-to-the-transformer-a-presentation-from-brainchip/
Chris Jones, Director of Product Management at BrainChip , presents the “Temporal Event Neural Networks: A More Efficient Alternative to the Transformer” tutorial at the May 2024 Embedded Vision Summit.
The expansion of AI services necessitates enhanced computational capabilities on edge devices. Temporal Event Neural Networks (TENNs), developed by BrainChip, represent a novel and highly efficient state-space network. TENNs demonstrate exceptional proficiency in handling multi-dimensional streaming data, facilitating advancements in object detection, action recognition, speech enhancement and language model/sequence generation. Through the utilization of polynomial-based continuous convolutions, TENNs streamline models, expedite training processes and significantly diminish memory requirements, achieving notable reductions of up to 50x in parameters and 5,000x in energy consumption compared to prevailing methodologies like transformers.
Integration with BrainChip’s Akida neuromorphic hardware IP further enhances TENNs’ capabilities, enabling the realization of highly capable, portable and passively cooled edge devices. This presentation delves into the technical innovations underlying TENNs, presents real-world benchmarks, and elucidates how this cutting-edge approach is positioned to revolutionize edge AI across diverse applications.
FREE A4 Cyber Security Awareness Posters-Social Engineering part 3Data Hops
Free A4 downloadable and printable Cyber Security, Social Engineering Safety and security Training Posters . Promote security awareness in the home or workplace. Lock them Out From training providers datahops.com
zkStudyClub - LatticeFold: A Lattice-based Folding Scheme and its Application...Alex Pruden
Folding is a recent technique for building efficient recursive SNARKs. Several elegant folding protocols have been proposed, such as Nova, Supernova, Hypernova, Protostar, and others. However, all of them rely on an additively homomorphic commitment scheme based on discrete log, and are therefore not post-quantum secure. In this work we present LatticeFold, the first lattice-based folding protocol based on the Module SIS problem. This folding protocol naturally leads to an efficient recursive lattice-based SNARK and an efficient PCD scheme. LatticeFold supports folding low-degree relations, such as R1CS, as well as high-degree relations, such as CCS. The key challenge is to construct a secure folding protocol that works with the Ajtai commitment scheme. The difficulty, is ensuring that extracted witnesses are low norm through many rounds of folding. We present a novel technique using the sumcheck protocol to ensure that extracted witnesses are always low norm no matter how many rounds of folding are used. Our evaluation of the final proof system suggests that it is as performant as Hypernova, while providing post-quantum security.
Paper Link: https://eprint.iacr.org/2024/257
Ivanti’s Patch Tuesday breakdown goes beyond patching your applications and brings you the intelligence and guidance needed to prioritize where to focus your attention first. Catch early analysis on our Ivanti blog, then join industry expert Chris Goettl for the Patch Tuesday Webinar Event. There we’ll do a deep dive into each of the bulletins and give guidance on the risks associated with the newly-identified vulnerabilities.
Dandelion Hashtable: beyond billion requests per second on a commodity serverAntonios Katsarakis
This slide deck presents DLHT, a concurrent in-memory hashtable. Despite efforts to optimize hashtables, that go as far as sacrificing core functionality, state-of-the-art designs still incur multiple memory accesses per request and block request processing in three cases. First, most hashtables block while waiting for data to be retrieved from memory. Second, open-addressing designs, which represent the current state-of-the-art, either cannot free index slots on deletes or must block all requests to do so. Third, index resizes block every request until all objects are copied to the new index. Defying folklore wisdom, DLHT forgoes open-addressing and adopts a fully-featured and memory-aware closed-addressing design based on bounded cache-line-chaining. This design offers lock-free index operations and deletes that free slots instantly, (2) completes most requests with a single memory access, (3) utilizes software prefetching to hide memory latencies, and (4) employs a novel non-blocking and parallel resizing. In a commodity server and a memory-resident workload, DLHT surpasses 1.6B requests per second and provides 3.5x (12x) the throughput of the state-of-the-art closed-addressing (open-addressing) resizable hashtable on Gets (Deletes).
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-EfficiencyScyllaDB
Freshworks creates AI-boosted business software that helps employees work more efficiently and effectively. Managing data across multiple RDBMS and NoSQL databases was already a challenge at their current scale. To prepare for 10X growth, they knew it was time to rethink their database strategy. Learn how they architected a solution that would simplify scaling while keeping costs under control.
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
Medicinal chemistry
1. Medicinal Chemistry: all you need to know
Summary:
The field of Medicinal chemistry offers a wide range of laboratory opportunities in pharmaceutical, biotechnological, and medical
device companies. Most chemists use their research abilities to formulate, produce, characterize, and investigate new compounds for
particular applications. The field connects many scientific disciplines to facilitate collaboration with scientists from those fields in
order to research and develop new drugs.
Medicinal chemistry connects many scientific disciplines to facilitate collaboration with scientists from those fields in order to
research and develop new drugs. The field of Medicinal chemistry offers a wide range of laboratory opportunities in pharmaceutical,
biotechnological, and medical device companies. Medicinal chemists focus on drug discovery and development and take concern in
isolating medicinal agents found in plants and the creation of new synthetic drug compounds as well. Most chemists use their
research abilities to formulate, produce, characterize, and investigate new compounds for particular applications. Most chemists in
conventional research careers are Ph.D. holders, while chemists having B.S. degrees usually serve as research technicians.
Medicinal chemistry is an inspiring field that connects many scientific disciplines to facilitate collaboration with scientists from those
fields in order to research and develop new drugs.
2.
3. Applying their chemistry expertise, medicinal chemists work in processing of synthesizing new pharmaceuticals. They also work for improving
the processes that make existing pharmaceuticals. Medicinal chemists focus on drug discovery and development and take concern in isolating
medicinal agents found in plants and the creation of new synthetic drug compounds as well.
Education:
• Most chemists in conventional research careers are Ph.D. holders, while chemists having B.S. degrees usually serve as research technicians.
Pharmaceutical companies generally, hire people having research exposure, advanced degrees in organic chemistry or biochemistry, and at
least two years of post-doctoral experience. There are a number of universities like National Institute of Pharmaceutical Education &
Research, University of Florida, University of Minnesota etc. that have medicinal chemistry departments, in association with biological
chemistry, pharmaceutical chemistry, pharmacology, or pharmacy programs.
Career Paths:
• Many medicinal chemists begin their career in the laboratory. They can work various laboratory career such as, formulation chemistry,
process chemistry, quality control or quality assurance.
• Research and development into how different chemicals affect biological systems
• Drug development that include formulation of drugs used to treat patients
• Testing possible new bio-active compounds in patient populations
4. They may also work in non-laboratory careers as in regulatory affairs, intellectual property, project management, or
technology transfer.
Workspace:
The field of Medicinal chemistry offers a wide range of laboratory opportunities in pharmaceutical, biotechnological,
and medical device companies. Most chemists use their research abilities to formulate, produce, characterize, and
investigate new compounds for particular applications. However, each lab setting is unique in respect to daily
activities and career opportunities. In certain cases, laboratory work is not always essential, for example, while
reviewing drug applications at the FDA.
Future Employment Trends:
Due to changing economy and government health care reform regulations, the forecast for this field is mixed.
Pharmaceutical firms have been downsizing their research laboratories, merging with other firms, and outsourcing
research for several years. Some outsourcing has also taken place overseas; this in turn reduces opportunities for
domestic pharmaceutical jobs. Small firms and contract research firms are some of the more promising places
offering employment in medicinal chemistry.
5. Key Points
• Medicinal chemists work in processing of synthesizing new pharmaceuticals.
• Pharmaceutical companies generally, hire people having research exposure, advanced degrees in
organic chemistry or biochemistry, and at least two years of post-doctoral experience.
• Medicinal chemists focus on drug discovery and development.
• They also take concern in isolating medicinal agents found in plants and the creation of new
synthetic drug compounds as well.
• They may also work in non-laboratory careers as in regulatory affairs, intellectual property,
project management, or technology transfer.
Published by Brainware University